Molecular Diagnostics

News on lab-developed tests and emerging diagnostic technologies.

OncoCyte Q3 Net Loss Up 73 Percent

The company incurred a net loss of $5.2 million, or $.10 per share, slightly exceeding the $.09 per share loss that analysts had predicted on average.

Linear Diagnostics Lands £2M Investment

The firm will use funds from the round, led by the Midlands Engine Investment Fund, to develop its optical point-of-care diagnostic testing platform.

Ikonisys, Sheba Medical Center Partner on Cancer Diagnostic Development

The partners will evaluate circulating tumor cell-based biomarker panels as potential new tests for use on Ikonisys' Ikoniscope fluorescence microscopy system.

Oncocyte Reaches Deal to Offer $8.5M to Certain Investors

The company said it intends to use net proceeds from the offering to support development and commercialization for its DetermaVu and Razor assays.

Biocartis Increases Instrument Placements, Cartridge Volume in Q3; Inks Japan Distribution Deal

The company signed a distribution agreement in Japan for its Idylla products and also initiated a listing of €150 million in unsecured convertible bonds.

Nov 14, 2019

Qiagen Upgraded to Overweight by JP Morgan; Stock Surges on Thermo Fisher Buyout Speculation

Nov 14, 2019

Fulgent Genetics Prices $26.2M Public Stock Offering

Nov 14, 2019

Curetis Posts 17 Percent Increase in Preliminary Revenues for First Nine Months of 2019

Nov 14, 2019

Inflammatix Inks BARDA Contract for up to $72M

Nov 13, 2019

Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences

Nov 13, 2019

Biocept Q3 Revenues Nearly Double

Nov 12, 2019

Adaptive Biotechnologies Q3 Revenues Rise 52 Percent

Nov 12, 2019

HTG Molecular Diagnostics Revenues Grow 15 Percent; Firm Lowers Full-Year Guidance

Nov 12, 2019

Exact Sciences Sues Johns Hopkins University for 'Improperly' Demanding Royalties

Nov 12, 2019

NorthBay Healthcare to Pilot GenomeSmart Genetic Test Recommendation Platform

Nov 12, 2019

AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

Premium

Nov 12, 2019

T2 Biosystems Q3 Revenues Drop 36 Percent; Firm Suffers Ransom Cyberattack

Nov 12, 2019

FDA Clears NantHealth Tumor-Normal Whole-Exome Test

Nov 12, 2019

Becton Dickinson Submits HPV Assay for Expanded US Premarket Approval

Nov 11, 2019

Castle Biosciences Q3 2019 Revenues Quadruple

Nov 11, 2019

Natera Outlines Plans for Cancer, Transplant Assays; Provides Update on Legal Proceedings

Premium

Nov 11, 2019

MDxHealth Revenues Down 35 Percent for Nine-Month 2019 Period

Nov 11, 2019

Invitae to Acquire Genetic Counseling Chatbot Developer for $50M

Nov 08, 2019

UPDATE: Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains

Premium

Nov 08, 2019

Bioneer Gets CE Mark for HCV Assay

The Scan

More Troubling Resistance

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

Many Dollar Bills There

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

'Transparency' Rule Proposed

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

Nature Papers Present Method for Simulating Hi-C Data, More

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.

Featured White Papers

Analytical Validation of the Oncomine Pan-Cancer Cell-Free Assay

A High-Performance Solution Combining CleanPlex OncoZoom Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations

Genetic Testing as a Tool for Improving Care and Outcomes for Patients with Rare Inherited Retinal Diseases

BlueBee Data Security & Compliance

Nov

19

Featured Webinar

Digital PCR for Tag Copy Number Assessment in CRISPR-Edited Cell Lines

Fluorescent proteins or self-labeling tags are invaluable tools for studying protein dynamics in living cells using fluorescence microscopy. However, quantitative imaging requires physiological levels of expression of the target protein of interest (POI), especially when stoichiometric interactions of the POI need to be investigated.

Dec

02

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec

04

Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

Menu

Molecular Diagnostics

What's Popular?

Sponsorships